Suppr超能文献

乙酸盐、硫酸盐和钙对A、B和E型肉毒杆菌神经毒素轻链催化活性的抑制作用

Inhibition of catalytic activities of botulinum neurotoxin light chains of serotypes A, B and E by acetate, sulfate and calcium.

作者信息

Mizanur Rahman M, Gorbet John, Swaminathan S, Ahmed S Ashraf

机构信息

Department of Cell Biology and Biochemistry, Integrated Toxicology Division, United States Army Medical Research Institute of Infectious Diseases Fort Detrick, Maryland 21702.

出版信息

Int J Biochem Mol Biol. 2012;3(3):313-21. Epub 2012 Sep 25.

Abstract

The catalytic domain, known as light chain (Lc), of the most poisonous botulinum neurotoxins (BoNTs), possesses endoprotease activity that triggers the ultimate poisonous effect to animals and humans. X-ray crystallographic structure of Lc of several BoNT serotypes has identified at least four small ligands at or near the respective active sites. They are sulfate ions in LcA, LcB, and LcE; an acetate ion in LcA; a calcium ion in LcB; and a potassium ion in LcD. Roles of these ligands on the structure and function of the proteins are not known. We have investigated the roles of sulfate, acetate, and calcium on the catalytic activities of LcA, LcB, and LcE using 17-35-residue synthetic peptide substrates. All three ligands inhibited all Lc activities. For LcA and LcB, the order of inhibition effectiveness was calcium>sulfate>acetate. The inhibition effectiveness expressed as IC(50), did not correlate with the occurrence or proximity of the ions to the active site. Moreover, addition of acetate or sulfate to LcA did not affect the near-UV circular dichroism spectra, tryptophan, and tyrosine fluorescence spectra, and mid points of thermal denaturation of LcA. Our results suggest that acetate, sulfate, and calcium nonspecifically interact with BoNT Lc, and their occurrence in the crystal structures could have been due to opportunistic binding to complementary pockets.

摘要

最具毒性的肉毒杆菌神经毒素(BoNTs)的催化结构域,即轻链(Lc),具有内蛋白酶活性,可引发对动物和人类的最终毒性作用。几种BoNT血清型的Lc的X射线晶体结构已在各自活性位点或其附近鉴定出至少四种小配体。它们在LcA、LcB和LcE中是硫酸根离子;在LcA中是一个醋酸根离子;在LcB中是一个钙离子;在LcD中是一个钾离子。这些配体对蛋白质结构和功能的作用尚不清楚。我们使用17 - 35个残基的合成肽底物研究了硫酸根、醋酸根和钙离子对LcA、LcB和LcE催化活性的作用。所有这三种配体均抑制了所有Lc的活性。对于LcA和LcB,抑制效果的顺序为钙离子>硫酸根>醋酸根。以IC(50)表示的抑制效果与离子在活性位点的出现或接近程度无关。此外,向LcA中添加醋酸根或硫酸根不会影响其近紫外圆二色光谱、色氨酸和酪氨酸荧光光谱以及LcA的热变性中点。我们的结果表明,醋酸根、硫酸根和钙离子与BoNT Lc发生非特异性相互作用,它们在晶体结构中的出现可能是由于与互补口袋的机会性结合。

相似文献

2
The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.
J Biol Chem. 2013 Aug 16;288(33):24223-33. doi: 10.1074/jbc.M113.451286. Epub 2013 Jun 18.
3
Tyrosine phosphorylation of botulinum neurotoxin protease domains.
Front Pharmacol. 2012 Jun 4;3:102. doi: 10.3389/fphar.2012.00102. eCollection 2012.
4
Differential role of molten globule and protein folding in distinguishing unique features of botulinum neurotoxin.
Biochim Biophys Acta. 2014 Jun;1844(6):1145-52. doi: 10.1016/j.bbapap.2014.02.012. Epub 2014 Feb 22.
6
Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3.
J Biol Chem. 2021 Jan-Jun;296:100684. doi: 10.1016/j.jbc.2021.100684. Epub 2021 Apr 21.
9
Resolution of sub-nanosecond motions in botulinum neurotoxin endopeptidase: An evidence of internal flexibility.
Biochim Biophys Acta. 2015 May;1854(5):321-6. doi: 10.1016/j.bbapap.2014.12.004. Epub 2015 Jan 9.

引用本文的文献

1
Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin.
PLoS One. 2014 Apr 25;9(4):e95188. doi: 10.1371/journal.pone.0095188. eCollection 2014.
3
The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.
J Biol Chem. 2013 Aug 16;288(33):24223-33. doi: 10.1074/jbc.M113.451286. Epub 2013 Jun 18.

本文引用的文献

1
Basic tetrapeptides as potent intracellular inhibitors of type A botulinum neurotoxin protease activity.
J Biol Chem. 2011 Jan 21;286(3):1802-11. doi: 10.1074/jbc.M110.146464. Epub 2010 Oct 20.
3
Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity.
Anal Biochem. 2010 Jan 15;396(2):188-93. doi: 10.1016/j.ab.2009.09.034. Epub 2009 Sep 24.
4
Substrate binding mode and its implication on drug design for botulinum neurotoxin A.
PLoS Pathog. 2008 Sep 26;4(9):e1000165. doi: 10.1371/journal.ppat.1000165.
5
Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A.
J Biol Chem. 2008 Jul 4;283(27):18883-91. doi: 10.1074/jbc.M801240200. Epub 2008 Apr 22.
7
Expression, purification, and characterization of Clostridium botulinum type B light chain.
Protein Expr Purif. 2006 Apr;46(2):256-67. doi: 10.1016/j.pep.2005.09.024. Epub 2005 Oct 26.
9
Role of metals in the biological activity of Clostridium botulinum neurotoxins.
Biochemistry. 2004 Mar 2;43(8):2209-16. doi: 10.1021/bi035844k.
10
Identification of the major steps in botulinum toxin action.
Annu Rev Pharmacol Toxicol. 2004;44:167-93. doi: 10.1146/annurev.pharmtox.44.101802.121554.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验